Health ❯ Mental Health ❯ Psychiatry

Depression

Psilocybin Suicidality GLP-1 Receptor Agonists Psychological Evaluation Psychedelic Treatment Emotional Distress Suicide Prevention Relapse Prevention Social Isolation GLP-1 Effects Treatment-Resistant Depression Anxiety Disorders PTSD Medication Risks Therapeutic Treatment Bipolar Disorder Post-Traumatic Stress Disorder Psychedelic Therapy Postnatal Depression Substance Abuse Treatment Treatment Methods Postpartum Disorders

Large Penn Study Finds GLP‑1 Use Tied to Lower Breast Cancer Rates

Researchers say the observational link points to metabolic and possible direct effects but call for randomized trials before changing care

Definium’s Oral LSD Pill Meets Primary Endpoint in Phase 3 Depression Trial

Study Finds Fathers’ Depression Risk Jumps a Year After Birth

Compass Pathways’ Psilocybin Therapy Hits Phase 3 Goal in Treatment-Resistant Depression

Slow Tapering With Therapy Matches Staying on Antidepressants, Major Review Finds

Single Psilocybin Dose Offers Long-Term Relief for Cancer-Related Depression